QSAR Based Design of New Antitubercular Compounds: Improved Isoniazid Derivatives Against Multidrug-Resistant TB

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|27|4427-4454

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.27, 2014-08, pp. : 4427-4454

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluoroquinolones, surgery in multidrug-resistant TB

By  

Inpharma, Vol. 1, Iss. 1445, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Multidrug-resistant TB `a curable disease'

By  

Inpharma, Vol. 1, Iss. 1298, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Synthesis and antitumor activity of novel podophyllotoxin derivatives against multidrug-resistant cancer cells

By Guo Yong-En  

Journal of Asian Natural Products Research, Vol. 13, Iss. 5, 2011-05 ,pp. : 417-424

Taylor & Francis Ltd

Access to resources Recommend Favorite

Recent Advances in QSAR-based Identification and Design of Anti-Tubercular Agents

By  

Current Pharmaceutical Design, Vol. 20, Iss. 27, 2014-08 ,pp. : 4418-4426

Bentham Science Publishers

Access to resources Recommend Favorite

A New Polymer–Lipid Hybrid Nanoparticle System Increases Cytotoxicity of Doxorubicin Against Multidrug-Resistant Human Breast Cancer Cells

By Wong Ho   Rauth Andrew   Bendayan Reina   Manias Janet   Ramaswamy Manisha   Liu Zengshe   Erhan Sevim   Wu Xiao  

Pharmaceutical Research, Vol. 23, Iss. 7, 2006-07 ,pp. : 1574-1585

Springer Publishing Company

Access to resources Recommend Favorite